Cite
HARVARD Citation
Gunnlaugsson, A. et al. (2022). A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial. Clinical and translational radiation oncology. pp. 77-82. [Online].